Hasan, Analyn A.
HRN: 24-50-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/23/2024
01/30/2024
IV
160mg
Every 6 Hours
T/C SSSS
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes